Perioperative medicine and pain management Other
Conditions
Interventions
Current interventions as of 11/10/2024:
The study is split into three phases.
Phase 1: In this phase of the study we will run a series of four focus groups each with a group of ICU survivors and/or
1) Exploration – contains several different immersive environments with simple narration to introduce the user to that environment and invite them to explore the setting.
2) Mindfulness and Motivation
Sponsors
Cwm Taf University Health Board
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 11/10/2024: 1. People with a previous admission to critical care within the last 5 years 2. Family members/ carers of a patient with a previous admission to critical care in the last 5 years 3. NHS employees involved in the care of critical care patients in ICU 4. NHS employees involved in the care and recovery of patients discharged from critical care (e.g. physiotherapists, psychologists, occupational therapists etc) Phase 3 feasibility study: - Adults with capacity to consent - Current hospital admission involving a stay in critical care, requiring organ support for more than 48 hours OR the loved one/ relative of someone admitted to critical care and is participating in the Phase 3 study - FOR ICU PATIENTS ONLY: If normal vocalization is not possible (due to tracheostomy) then the participant must have an established method of communication with bedside nurse/ ward staff _____ Previous inclusion criteria: Phase 1 focus groups: 1. People with a previous admission to critical care within the last 5 years 2. Family members/ carers of a patient with a previous admission to critical care in the last 5 years 3. NHS employees involved in the care of critical care patients in ICU 4. NHS employees involved in the care and recovery of patients discharged from critical care (e.g. physiotherapists, psychologists, occupational therapists etc) Phase 3 feasibility study: 1. Adults with capacity to consent 2. Recent (within 4 weeks) admission to critical care requiring organ support for more than 48 hours 3. Any phase 1 participant that wishes to trial the intervention in phase 3 will be allowed to do so
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 11/10/2024: Phase 1 focus groups: 1. Any person unable to provide informed consent 2. Any person unable to communicate in English Phase 3 feasibility study: - FOR PATIENTS ONLY: Any person experiencing delirium as assessed daily using CAM-ICU - A history of severe motion sickness - A history of photosensitive epilepsy - Any physical or anatomical contraindications to using VR headsets (e.g. severe visual or hearing impairment, major skull or facial surgery). [This does not include those that may require assistance to place the headset due to muscle weakness from ongoing admission.] - Any person unable to communicate in English _____ Previous exclusion criteria: Phase 1 focus groups: 1. Any person unable to provide informed consent 2. Any person unable to communicate in English Phase 3 feasibility study: 1. Any person with a recent critical care admission still experiencing ongoing issues with delirium 2. A history of severe motion sickness 3. A history of photosensitive epilepsy 4. Any physical or anatomical contraindications to using VR headsets (e.g. severe visual or hearing impairment, major skull or facial surgery) 5. Any person unable to communicate in English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome for the Phase 3 study is feasibility and acceptability as determined by; recruitment, retention, intervention adherence and data completion measured using patient records at the end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 11/10/2024: The secondary outcomes will include: 1. EQ5D 2. ICECAP-A 3. Brief resilience Scale 4. Richard Campbell Sleep Questionnaire 5. DASS-10 _____ Previous secondary outcome measures: The secondary outcomes to be included will be decided as part of Phase 1 activities and these will be updated on the conclusion of Phase 1 and phase 2. They are expected to include: 1. A quality of life measure, such as the EQ-5D or ICECAP-A 2. A measure of psychological well-being such as the hospital anxiety and depression scale (HADS) 3. General well-being scale 4. Sleep measure 5. A healthcare resource use measure 6. A measure of cognitive performance such as the Montreal Cognitive Assessment (MOCA) | — |
Countries
United Kingdom, Wales
Outcome results
None listed